Literature DB >> 30778621

Risk factors of intracranial hemorrhage after mechanical thrombectomy of anterior circulation ischemic stroke.

Ulf Neuberger1, Philipp Kickingereder1, Silvia Schönenberger2, Simon Schieber2, Peter A Ringleb2, Martin Bendszus1, Johannes Pfaff1, Markus A Möhlenbruch3.   

Abstract

PURPOSE: Intracranial hemorrhage (ICH) is a potentially severe complication after mechanical thrombectomy (MT). Here, we investigated risk factors for the occurrence of any and symptomatic ICH after MT due to large-vessel occlusion of the anterior circulation.
METHODS: Consecutive patients with acute ischemic anterior circulation stroke with large-vessel occlusion undergoing MT were analyzed. ICH was categorized according to the Heidelberg Bleeding Classification. Forty-three procedural and clinical parameters were analyzed using univariate tests and multivariate logistic regressions.
RESULTS: Of 612 patients, any ICH was detected in 195 (31.9%), while 27 (4.4%) developed a symptomatic ICH. Infarct size > 1/3 of vascular territory in control imaging (OR 2.18, 95% CI 1.45-3.21), higher serum glucose levels (OR 1.23 for change of 15 units mg/dL, 95% CI 1.10-1.39), and higher thrombectomy maneuver count (OR 1.21, 95% CI 1.11-1.32) were significantly associated with a higher risk of developing any ICH compared to no ICH. Wake-up strokes (OR 3.99, 95% CI 1.38-11.60), transfer from an external clinic (OR 3.04, 95% CI 1.24-7.48), and higher serum glucose levels (OR 1.22 for change of 15 units mg/dL, 95% CI 1.05-1.42) were revealed as independent risk factors for development of symptomatic ICH compared to no symptomatic ICH. Patients with no infarct demarcation (OR 0.10, 95% CI 0.01-0.80) and complete recanalization (OR 0.57, 95% CI 0.37-0.86) showed a lower risk of developing any ICH.
CONCLUSION: Wake-up strokes and patients who are treated within a drip-and-ship concept are especially vulnerable for symptomatic ICH, while complete recanalization, contrary to subtotal recanalization only, was revealed as a protective factor against ICH.

Entities:  

Keywords:  Hemorrhagic transformation; Intracranial hemorrhage; Ischemic stroke; Mechanical thrombectomy; Risk factors

Mesh:

Year:  2019        PMID: 30778621     DOI: 10.1007/s00234-019-02180-6

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  9 in total

1.  Intracranial hemorrhage risk factors after thrombectomy in anterior circulation ischemic stroke.

Authors:  Chirag Jain
Journal:  Neuroradiology       Date:  2019-08-30       Impact factor: 2.804

2.  Pre-procedural predictive factors of symptomatic intracranial hemorrhage after thrombectomy in stroke.

Authors:  Laura Venditti; Olivier Chassin; Claire Ancelet; Nicolas Legris; Mariana Sarov; Bertrand Lapergue; Cristian Mihalea; Augustin Ozanne; Sophie Gallas; Jonathan Cortese; Vanessa Chalumeau; Leon Ikka; Jildaz Caroff; Julien Labreuche; Laurent Spelle; Christian Denier
Journal:  J Neurol       Date:  2021-01-03       Impact factor: 4.849

Review 3.  Acute ischaemic stroke: challenges for the intensivist.

Authors:  M Smith; U Reddy; C Robba; D Sharma; G Citerio
Journal:  Intensive Care Med       Date:  2019-07-25       Impact factor: 17.440

4.  Predictors of intracranial hemorrhage in acute ischemic stroke after endovascular thrombectomy.

Authors:  Masaya Enomoto; Keigo Shigeta; Takahiro Ota; Tatsuo Amano; Masayuki Ueda; Yuji Matsumaru; Yoshiaki Shiokawa; Teruyuki Hirano
Journal:  Interv Neuroradiol       Date:  2020-05-31       Impact factor: 1.610

5.  MiR-199a-5p inhibition protects cognitive function of ischemic stroke rats by AKT signaling pathway.

Authors:  Xianghui Zhang; Guan'en Zhou
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

6.  Computed tomography features of spontaneous acute intracranial hemorrhages in a tertiary hospital in Southern Ghana.

Authors:  Emmanuel Kobina Mesi Edzie; Klenam Dzefi-Tettey; Edmund Kwakye Brakohiapa; Philip Narteh Gorleku; Eric Aidoo; Kwasi Agyen-Mensah; Peter Appiah-Thompson; Adu Tutu Amankwa; Ewurama Andam Idun; Frank Quarshie; Richard Ato Edzie; Benard Osei; Prosper Dziwornu; Abdul Raman Asemah
Journal:  Pan Afr Med J       Date:  2021-12-16

7.  Predictors of mortality in acute ischemic stroke treated with endovascular thrombectomy despite successful reperfusion: subgroup analysis of a multicentre randomised clinical trial.

Authors:  Hao Li; Jinbo Huang; Shisheng Ye; Hai Chen; Li Yuan; Geng Liao; Weijie Du; Chaomao Li; Ling Fang; Sheng Liu; Pengfei Yang; Yongwei Zhang; Pengfei Xing; Xiaoxi Zhang; Xiaofei Ye; Ya Peng; Jie Cao; Liyong Zhang; Zhi Yang; Jianmin Liu
Journal:  BMJ Open       Date:  2022-03-01       Impact factor: 2.692

8.  Eptifibatide use in ischemic stroke patients undergoing endovascular thrombectomy: A matched cohort analysis.

Authors:  Ameena Rana; Siyuan Yu; Savina Reid-Herrera; Scott Kamen; Krystal Hunter; Hamza Shaikh; Tudor Jovin; Olga R Thon; Parth Patel; James E Siegler; Jesse M Thon
Journal:  Front Neurol       Date:  2022-09-27       Impact factor: 4.086

Review 9.  Therapeutic Nanoparticles for the Different Phases of Ischemic Stroke.

Authors:  Sara Bernardo-Castro; Inês Albino; Ángela María Barrera-Sandoval; Francesca Tomatis; João André Sousa; Emanuel Martins; Susana Simões; Miguel M Lino; Lino Ferreira; João Sargento-Freitas
Journal:  Life (Basel)       Date:  2021-05-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.